Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Bruce Lyday

Message the company or request a 1:1 meeting here

Startup Biotech in Southern California focused on new vaccine technology for SARS-2, HIV, and other viral diseases. Founders have extensive Biotech experience, 4 exits, 1 IPO. Tech leverages power of mucosal immunity, lacking in mRNA designs, to provide sterilizing immunity to Omicron and other mutant strains. Currently in Pre-clinical development stage after raising seed round.